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ABSTRACT: In addition to a multitude of genetic and
biochemical alterations, abnormal morphological, structural,
and mechanical changes in cells and their extracellular
environment are key features of tumor invasion and metastasis.
Furthermore, it is now evident that mechanical cues alongside
biochemical signals contribute to critical steps of cancer
initiation, progression, and spread. Despite its importance, it is
very challenging to study mechanics of diﬀerent steps of
metastasis in the clinic or even in animal models. While
considerable progress has been made in developing advanced
in vitro models for studying genetic and biological aspects of
cancer, less attention has been paid to models that can capture
both biological and mechanical factors realistically. This is
mainly due to lack of appropriate models and measurement tools. After introducing the central role of mechanics in cancer
metastasis, we provide an outlook on the emergence of novel in vitro assays and their combination with advanced measurement
technologies to probe and recapitulate mechanics in conditions more relevant to the metastatic disease.
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■ INTRODUCTION
Metastatic disease is the major clinical complication in most
types of cancer and the cause of more than 90% of cancer-
related deaths.1−3 During this complex, multistep process
(Figure 1), tumor cells that acquired an invasive phenotype4−6
dislodge from the primary tumor,7 enter the blood or lymphatic
microvasculature (intravasate),8,9 and following survival in
blood circulation,10 possibly exit from microvessels (extrava-
sate) of distal tissues11 and form secondary tumors (colonize)
within vessels and in distant organs.12 Irregular mechanical
alterations in cells and the extracellular environment has made
it increasingly apparent that mechanics and mechanical
signaling play a central role at all stages of the metastasis
cascade.13−15 However, despite notable progress in the
development of in vitro 3D models capable of recapitulating
key features of metastasis more realistically,16−18 the cell
mechanics and mechanobiology research have been predom-
inantly concentrated on 2D cells in Petri dish models. Although
in in vivo models it is very diﬃcult or almost impossible to
probe mechanical features of cancer metastasis particularly at
the cellular scale, 2D models, as a ﬁrst simple reductionist
approach, have been pivotal in widening the basic under-
standing of cancer mechanobiology.19 Yet, critical steps of
cancer metastasis including tumor invasion, intravasation and
extravasation are inherently 3D processes occurring in
microenvironments rich in complex biomechanical cues.
Therefore, furthering our understanding of mechanics in cancer
metastasis requires the development of in vitro models and
their integration with advanced measurement technologies for
quantitative analysis.
■ MECHANICS IN CANCER METASTASIS
Transformation of tumor cells to an aggressive and migratory
phenotype is a key step leading to dissemination of cancer cells
in the body.20,21 Decades of research have been focused on the
genetic and epigenetic basis of the oncogenic transformation.
Although mechanical signals as an epigenetic factor might have
a signiﬁcant role in tumorigenesis,22−25 the role of mechanics
and mechanical signaling during malignant transformation of
tumor cells is critical: (1) Tumor mass is both a mechanically
and biologically diverse environment. (2) Cells are mechano-
sensitive and respond to both biological and mechanical cues.
(3) Morphological alteration and inappropriate migratory
behavior of tumor cells (such as those observed during tumor
cell epithelial−mesenchymal transition and collective migra-
tion26) are mainly driven by aberrations in cytoskeletal
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remodelling and cell adhesion,27 which are clear signatures of
malignancy. (4) Cellular morphogenesis, migration, and
rheological properties are determinant factors in all post-
invasion stages including intravasation, circulation, and
extravasation.
Tumor Microenvironment: A Biomechanically Aber-
rant Tissue. Disruption in key physiological cellular processes
such as cell cycle leads to loss of tissue homeostasis and tumor
formation, a precursor to invasion and metastasis. A solid tumor
with recognizably increased stiﬀness is made of primary cancer
cells and a collection of stromal cells such as immune cells,
stromal ﬁbroblasts, and vascular endothelial cells that are
embedded in the extracellular matrix (ECM) and nourished
through the vascular system resulting from angiogenesis
(Figure 1). The special composition of tumors and the
complex interactions among cancer cells, immune cells, stromal
cells, and the ECM lead to a structurally and mechanically
irregular microenvironment unique to solid tumors.28,29 For
example, cell morphology and organization exhibit diﬀerent
patterns compared to normal tissue, the composition and 3D
structure of the ECM that consists of a ﬁbrous mesh of proteins
are remodeled and continuously evolve during tumor
progression, microvessels are often excessively branched and
exhibit abnormal dilated, tortuous, elongated, and sacculated
shapes. In addition to the irregular heterogeneous architecture
of tumor microenvironment, the rapid proliferation of cancer
cells pushes against the surrounding normal tissue and causes a
buildup of pressure within the tumor that is known as growth
induced solid stress.30,31 Furthermore, stress accumulates
within the interstitial ﬂuid phase of the tumor mass as a result
of morphological and architectural abnormalities of blood
(leading to increased permeability) and lymphatic microvessels
and unnatural interaction of the ﬂuid with solid phase of the
tumor.32
Mechanical Signaling, Mechanosensitivity, and Me-
chanotransduction. During both physiological and patho-
logical conditions, cells sense diﬀerent mechanical cues through
various complex sensory machinery located on diﬀerent cellular
sites such as stretch-gated ion channels and focal adhesions.33,34
Mechanical cues can originate from direct application of
diﬀerent types of forces on the cell, such as tensile, compressive,
pressure, and shear forces, or structural and mechanical
properties of the cellular environment such as stiﬀness and
the microstructural architecture of the ECM.35−37 Signals
detected via mechanosensory systems activate intracellular
signaling cascades which result in transduction of mechanical
cues into intracellular biochemical events that in turn regulate
cellular behavior and function such as the cell cycle,
morphogenesis, and migration.38 In the context of cancer
invasion, unique biomechanical signals generated during tumor
initiation and progression perturb the normal behavior of cells
within and adjacent to the tumor, and the initiation of complex
biomechanical signaling and mechanotransduction processes
can expedite the transformation of primary cancer cells to a
Figure 1. Mechanics in metastatic cascade. A primary tumor, which constitutes a highly abnormal biochemical environment, is formed because of
oncogenic mutations and genetic and epigenetic cues. Following tumor formation, some tumor cells acquire a malignant phenotype with
inappropriate adhesion, morphology and motility. In addition to biological signals, mechanical cues unique to the tumor microenvironment such as
solid stress, interstitial ﬂuid pressure, and ECM structure coordinate acquisition of an invasive phenotype and initiation of the cascade of metastatic
events. Invasive cancer cells orchestrate unique force−interaction with cells, ECM, and interstitial ﬂuid, to detach from the primary tumor and
migrate through ECM to reach the vascular network and intravasate into the microvessels. Under the forces of blood ﬂow, the intravasated cancer
cells disperse into circulation, and those that survive can become lodged in and extravasate from the microvasculature to invade the tissue at the
secondary site.
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malignant phenotype.22,39−42 Furthermore, after acquisition of
invasive behavior, to move through surrounding tissue, respond
to signals, and overcome a variety of biomechanical barriers,
cancer cells must employ robust cellular migration and shape
change strategies through regulation of their cytoskeletal
dynamics.43
Cytoskeleton, Cell Migration, and Rheology. Cytoske-
letal processes drive cancer metastasis by enabling the invasion
and spread of cancer cells.44 Because cytoskeleton drives cell
division and regulates cell cycle, it has a prominent role in
tumor initiation and progression. Furthermore, cytosketal
remodelling via actin polymerization and acto-myosin con-
traction together with cell adhesion are the fundamental
determinants of cellular morphogenesis, migration, and
mechanical properties.45 Hence almost all steps of cancer
dissemination that require cell motility are inﬂuenced by
cytoskeleton dynamics. Although cytoskeletal reorganization
provides the forces for morphogenesis and migration, the
maximal rate at which shape change and migration can occur is
dictated by the rate at which the cell can be deformed.46,47
Hence, in addition to physical inﬂuences of the extracellular
environment,48 the dynamic mechanical properties or rheology
of the cell is a rate limiting factor for cancer cell migration.47
Fascinatingly, it is becoming increasingly recognized that cells
with higher metastatic potential are softer49,50 but generate
stronger forces51,52 compared to nonmetastatic cells, allowing
them to squeeze through 3D ECM and metastasize more
readily.53 On the other hand, it has been suggested that cancer
cells may also become stiﬀer because of increased actomyosin
contractility.54 Dissecting eﬀects of diﬀerent mechanical factors
such as cellular adhesions, force generation, and stiﬀness is,
however, not conclusive and requires wider examination.
■ PROBING THE MECHANICS: CHALLENGES AND
EMERGING OPPORTUNITIES
Investigating mechanics of cellular systems requires probing (1)
morphological changes, (2) mechanical properties, and (3)
force interactions of live cells and extracellular environment.
Light microscopy including confocal and epiﬂuorescence
techniques have been extensively used to investigate cell
morphological changes and migration.55 Measurement of
mechanical properties is based on the application of forces or
deformations and probing the concomitant deformations, or
forces, respectively.56 A variety of mechanical measurement
techniques such as magnetic twisting cytometry, magnetic
tweezers, optical tweezers, substrate cell stretchers, shear ﬂow
rheometry, and atomic force microscopy have been utilized to
investigate cell mechanics and mechanical models.57,58
However, inherent limitations in these technologies such as
imaging depth and necessity of physical contact restrict their
application to investigate cell mechanics mostly in a well-plate,
2D assay.
Furthermore, cancer metastasis occurs in a complex
physicochemical environment. In all metastatic subevents,
mechanosensing and mechanotransduction take place in a
landscape composed of diverse cell types dynamically
interacting with spatiotemporally evolving ECM of heteroge-
neous composition and mechanical properties. Therefore,
forces generated by endothelial, stromal and cancer cell types,
and forces acting among these cell types and mediated by the
surrounding ECM are also dynamic, and thus challenging to
measure. Compositionally, intracellular and extracellular
elements are multiphasic; stresses and forces can be exerted
by both the ﬂuid (e.g., ﬂuid ﬂow shear forces, hydrostatic
interstitial pressures) and the solid domains (e.g solid stress,
cell−cell, and cell−matrix force interactions), encompassing
mechanical feedback in many cell motility events under
chemical (chemotaxis), compositional (e.g., haptotaxis, dur-
otaxis), or even electrical (galvanotaxis) stimuli, to name a few.
These complexities push researchers toward multifaceted
experimental and computational techniques. One central issue
is thus in the choice of proper in vitro methodologies for the
observation and characterization of mechanics in metastasis.
Here, we identify ﬁve main challenges that are also emerging
opportunities for future research.
Imaging. A key challenge for imaging technologies is to
precisely capture relevant metastatic events while additionally
obtaining mechanical readouts from these images or other
independent mechanical tools. Major advances in imaging have
often had a profound impact on our ability to quantify
mechanics in metastatic processes. At the subcellular scale,
satisfactory resolution within intact tissues is currently hard to
achieve. Optical super-resolution imaging has given insights at
the molecular scale, e.g., imaging clustering and localization of
single molecules.59 Although relevant, these high-resolution
assessments are currently limited to speciﬁc applications,
certainly far from being capable of measuring mechanics over
a large dynamic range of metastatic events. Advanced in vivo
imaging techniques are enabling assessment of tumor
pathophysiology at a higher resolution, and in an intact host.
For instance, intravital imaging, requiring an appropriate animal
model, can measure anatomical and functional parameters
linked to the mechanics of metastatic events.60 Intravital
imaging can assess how invasive tumor cells move, and more
generally the mechanisms of cell migration during invasion and
intravasation.61 Because of the capability for imaging deeper
within a sample than other light microscopy, intravital
measurements might prove eﬀective to study mechanics in
cancer metastasis, despite the inability to control key
parameters during in vivo imaging. Other interesting
approaches are the (micro)elastography methods that are
mostly focused at establishing the correlations between intra-
and extra-cellular stiﬀness with cancer malignancy. These
methods are classically applied along with magnetic resonance
imaging,62 or more recently using optical coherence tomog-
raphy.63 New discoveries can be achieved from the above-
mentioned advances in the imaging ﬁeld and from powerful
combinations of diﬀerent techniques, especially in the creation
of new 3D models of metastatic processes in deep tissues with a
multiscale possibility of precisely quantifying relevant spatio-
temporal events,64 and properties (such as stiﬀness in
elastography). Noninvasive imaging with aﬀordable in vivo
models of 3D tissue microenvironments relevant for cancer
metastasis65 can boost the therapeutic and drug screening
relevance, provided limitations related to immunocompromised
microenvironment and histological appearance are targeted.66
Moreover, reproducing and imaging 3D models of metastatic
processes at the micrometer and submicrometer scale to
understand force exchanges among the cellular entities involved
requires an elevated level of control in real-time 3D imaging,
currently achievable with proper re-engineered metastatic
microenvironments.
Realistic in Vitro Models: Engineered Microenviron-
ment. In vitro models dramatically increase the potential for
precise control of parameters and accurate mechanical
quantiﬁcation in cancer metastasis and open its unique cellular
ACS Biomaterials Science & Engineering Review
DOI: 10.1021/acsbiomaterials.7b00041
ACS Biomater. Sci. Eng. XXXX, XXX, XXX−XXX
C
environment for experimental attack. A plethora of in vitro
models is available for malignant cells in 2D.67 While these 2D
cancer models are consolidated high-throughput tools for many
applications (e.g., drug screening), more realistic cellular
environments have provided very diﬀerent clinical outcomes
when compared to the 2D situation.68 In 2D, cancer cells
organize as a monolayer, structurally distinct from the 3D
physiological situation. This dimensional preconditioning
produces very diﬀerent mechanobiological signaling.69,70
Ubiquitous characteristics of 3D tumors, such as the hypoxic
environment inside tumor masses, are not possible to
recapitulate in 2D cell cultures. Moreover, a metastasis-
mimicking microenvironment must include the vasculature or
the endothelial monolayer, and the stromal extracellular
environment (Figure 2). Ad hoc 3D culture systems can be
designed depending on the research question; for instance, the
use of 3D spheroidal cultures, mimicking early events of
metastasis and intravasation, can unravel interesting mecha-
nobiology-dependent phenomena that are depending on cell−
cell or cell−matrix adhesions and possible to target therapeuti-
cally.71,72 Realistic models of microvasculature on a chip have
been developed using microﬂuidics, and have been combined
with other complex environments and interactions, including
immune cells.73−76 Such organ and disease models have
provided novel characteristics and outputs such as physiolog-
ically relevant capillary morphologies and values of vascular
permeability, excellent imaging and real-time monitoring
capabilities, all extremely valuable for the study of metastasis.
The possibility of controlling applied ﬂuid ﬂows and
pressuresubiquitous stimuli in physiology and diseaseis
another advantage of microﬂuidics-based engineered micro-
environments.77,78
Biomaterials Technologies. Designing, fabricating, and
integrating tumor-recapitulating ECM is the essence of
transforming 2D assays to 3D realistic in vitro models of
metastasis. However, having a custom-designed biomaterial for
in vitro setting that is fully compatible with the complex in vivo
ECM while appropriate for testing diﬀerent mechanical eﬀects
is a critical challenge of the ﬁeld because every single feature of
the biomaterial that is dissimilar, such as composition, structural
organization, architecture, and mechanical stiﬀness, can
potentially inﬂuence both biological and physicals behaviors
of the cell.79,80 For example, although the use of ECM-
mimicking natural biopolymers, such as collagen, ﬁbrin, or
matrigel, could increase the clinical relevance of the in vitro
environment via reproducing realistic biochemical and
mechanical signaling,81 they lack tight control of mechanobi-
ology-related cues such as mechanical stiﬀness, degradation
rate, porosity, and cell adhesion site number.79 An increasing
number of studies that used synthetic biomaterials, have instead
been able to precisely tune environmental cues by controlling
MMP-degradable sequences, the density of adhesions sites or
signaling ligands, and gradients of stiﬀness.82−84 Systematically
targeting the eﬀect of these microenvironmental parameters on
adhesion, migration, and cellular forces in cancer metastasis,
can generate relevant experimental throughput; provided these
microenvironments are compatible with the tools for imaging
and measuring mechanical quantities and that care is taken to
Figure 2. Engineering of a metastasis-mimicking microenvironment and examples of compatible tools for probing the mechanics. (Left) Schematic
of a proposed platform integrating imaging and force measurement methodologies with an in vitro model of cancer metastasis. The model has
microenvironmental features such as the coexistence of a microvascular network with stromal cells and biomechanical stimuli such as ﬂuid ﬂow and
ﬁbrous biopolymers. (Right) Three recent examples of stiﬀness, ECM deformation, and molecular force assessments. Reproduced with permission
from refs 85−87. Copyright 2015−2016 Nature Publishing Group.
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clearly distinguish the eﬀects of mechanical stiﬀness from those
of ligand density. Notably, because it is impossible to
recapitulate the complex 3D biomechanical characteristics of
wide variety of cancer types, a reductionist approach, for
example, by designing hybrid biomaterials taking certain
advantages of natural and synthetic materials, can pave the
way to study and dissect eﬀects of speciﬁc features of the tumor
microenvironment.
Mechanical Measurement Techniques. Force Measures.
The accurate and relevant measurement of mechanical
quantities in vitro needs a proper combination of high-
resolution imaging capabilities, mechano-sensitive readouts,
and a metastasis-mimicking microenvironment. In one 2D
study of this kind, researchers quantiﬁed traction forces of
several malignant cells on diﬀerent substrates, and concluded
that contractile forces exerted by these cells are higher on stiﬀ
substrates and at the later stage of the disease.88 The authors
employed 2D traction force microscopy (TFM), a tool that
includes the imaging of the deformation of ﬁducial markers
tethered to the cellular and extracellular matrix, and the
computational procedure to back-calculate the cellular forces
that generated the deformation. 2D TFM has been extensively
used in cell mechanobiology; however, to tackle the mechanics
of metastasis, TFM in 3D is essential,89 with application to
collective multicellular entities,90 and the measurement of
traction force in physiologically relevant 3D ECMs, i.e.
elastically nonlinear and spatiotemporally remodelled.86,91 For
that, an accurate mapping of mechanical properties in
remodelled ECMs at the cell level needs advanced imaging to
probe the local composition of cellular and extracellular
domains.
Stiﬀness Measures. More locally and deeper in tissue than
AFM, magnetic and optical tweezers in microscope setups are
powerful tools for local assessment of mechanical proper-
ties29,92 and could be directly used in 3D metastasis-mimicking
in vitro studies. Another example is confocal Brillouin
microscopy which is a promising noncontact method for
characterization of both extra- and intracellular compositionally
and mechanically driven remodelling during metastatic events.
The Brillouin scattering technique measures interaction
between light and spontaneous acoustic phonons (i.e.,
thermally generated longitudinal vibrational waves) and
determines the optical frequency shift of the scattered light
indicating the longitudinal compressive modulus of the
material.93 This technique has been recently integrated with
confocal microscopy and provided a robust noncontact tool for
determining local hydro-mechanical stiﬀness properties in cell
and tissue constructs.85
Another interesting opportunity arises in the use of
molecular strain sensors, for instance the ones functionalizing
structural biological molecules (such as cadherins) involved in
disease with ﬂuorescent resonance energy transfer (FRET)
technologies.94−96 For instance, extracellular ﬁbronectin can be
successfully engineered as a mechano-sensitive FRET probe.87
The physiological unfolding of structural molecules reﬂects
local microenvironmental mechanics, despite the diﬃculties in
the correlation between force and molecular strain and
unfolding. Finally, other force measurement tools could be
used to unravel the force interactions in metastatic events, such
as 3D laser ablation,97,98 cellular force inference,99 or
extracellular liquid droplets, where deformation is inferred
from the counter-action of cellular forces and surface tension of
the droplet.100
Computational Modeling Advances. Computational (in
silico) methods should be used in combination with in vitro
approaches in any comprehensive biophysical study and
modeling mechanics during metastasis is no exception.
Computational models are essential for the analysis and
interpretation of experimental and imaging data (e.g., in 3D
TFM), provide insight and generate new hypotheses, facilitate
the design of new experiments, enable systematic parameter
variation, and test ideas hardly testable with experiments. The
reliability of a computational model must be extensively
evaluated with experiments through prediction, experimental
veriﬁcation, and model revision, often requiring an iterative
approach. Several computational models of cancer metastasis
exist, spanning from atomistic to continuum, and have been
extensively reviewed elsewhere.101−103 These have predicted
speciﬁc aspects of cancer metastasis such as extracellular
remodelling-induced proliferation, cell protrusive growth along
stiﬀness gradients, or the positive correlation of cell stiﬀness
and contractility with migration and growth rates.
Future eﬀorts should point to novel model formulations for
(1) the understanding of cell−ECM force interactions,
particularly paving the way for numerical frameworks for
ECM degradation and remodelling, (2) linking spatiotemporal
modeling scales (and generating multiscale models), (3)
integrative hybrid discrete-continuum modeling strategies104
toward a systems biology perspective that focuses on emergent
properties of collective entity (applicable to cancer spheroids,
tumorigenesis, or the endothelial barrier) rather than on the
reductionist study of the parts. Computational advances along
these lines will continue to provide new insights into the
mechanobiology of the complex metastatic milieu.
■ INTEGRATIONS AND FUTURE DIRECTIONS
Finding a cure for a complex disease such as cancer necessitates
understanding of the disease from every aspect, from complex
genetics and biological signaling to physical interactions and
mechanical properties of individual cells. So far, we have
summarized the state-of-the-art characterization of mechanical
interactions in metastasisan increasingly critical issue to
understand cancer dissemination. The force interactions
between tumor cells and ECM and the concomitant eﬀects of
stromal and immune cell types can be accessed by ﬁnely tuning
the biomaterials encapsulating these cell types in 3D. Several
stimuli can be applied, and a ﬁrst integration with computa-
tional models is necessary to design the experiments and
quantify how ECM properties, ﬂuid ﬂows, and external forces
aﬀect the mechanobiological interactions. Deviations from
physiological values of such stimuli and correlation with several
pathologies or drugs can be studied. Computational models
should continuously challenge these experiments and help in
redeﬁning the mechanobiology signiﬁcance of results; for
instance, new mechanobiological readouts can be predicted
from pathways implemented in computational network models
validated by the experimental output, therefore suggesting new
exciting experiments and accelerating discoveries.
For all these applications, tissue engineering and biomaterials
advances provide continuous inspiration for in vitro modeling.
Assembly techniques such as bioprinting and controlled
spheroid formation will dictate how to produce sophisticated
3D environments that realistically recapitulate the metastatic
niche;66 moreover, we have shown how force interactions are
measurable with a plethora of methods. Thus, a further
integration among techniques should focus on those assemblies
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and functionalized natural or synthetic polymers that can
accommodate molecular force and stiﬀness sensors, and
increase their throughput by controlling the biological
complexity, e.g., the use of 3D stiﬀness gradients in ECM-
mimicking polymers.
Beyond characterization, using and integrating techniques
from the described palette with other advanced genetically and
biologically focused approaches can answer clinically relevant
questions and eﬀectively pave the way for personalized cancer
medicine. A promising avenue for future research is to combine
genetic and functional proﬁle information in determining
cancer progression and drug eﬃcacy. For example further to
directly investigating mechanobiological hypotheses, because
high-throughput in vitro models of mechanics in cancer
metastasis provide more advanced biomechanical readouts,
they can be readily used in combination with transcriptional
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